Cover Image


Subcutaneous Self-Administration Markets to 2022

出版商 Greystone Research Associates 商品編碼 320682
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
皮下自我施打市場 Subcutaneous Self-Administration Markets to 2022
出版日期: 2014年12月09日 內容資訊: 英文




  • 皮下給藥
  • 需求促進要素
  • 競爭情形
  • 風險因素


  • 人體工學及可用性
  • 安全功能
  • 針頭保護裝置
  • 針插入深度
  • 故障保險裝置(雙重安全裝置)啟動
  • 投藥檢驗/注射確認
  • 冷凍乾燥藥/重組


  • 自我施打SC藥的給藥


  • 抗凝固劑
  • 抗病毒藥
  • 自體免疫疾病
  • 糖尿病
  • 造血
  • 荷爾蒙補充
  • 神經學
  • 骨質疏鬆症
  • 生產健康


  • 法規問題
  • DTC行銷
  • 患者教育


Product Code: SSA995R

Subcutaneous Self-Administration Markets to 2022: Drugs, Devices, Therapeutics, Markets and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the therapeutics, markets, participants and commercial opportunities for drugs and combination products designed to be self-administered subcutaneously. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Market and Product Evolution in the Injectable Drug Sector

As healthcare markets continue to evolve, drug developers and their supply chain partners are attempting to keep pace by addressing economic, market and therapeutic factors that increasingly revolve around how, when and where drugs are administered. This evolution is being driven by new and exciting options for patient care in the form of powerful drug therapies for treating diseases with improved outcomes and for treating diseases for which an effective treatment did not previously exist. Beyond oncology - where therapeutics continue to be supplied for administration via infusion - the majority of new non-oral drugs are being formulated for subcutaneous injection. Many of these drugs are indicated for chronic conditions, which because of the continuous need for dosing over time benefit significantly when patients can self-administer their medication. This report examines in detail the drugs, devices, therapeutics and markets that are set to change substantially over the remainder of the decade.


  • Provides detailed analysis of self-administered subcutaneous drug products, drug delivery and device strategies, and product development factors
  • Assesses key markets, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
  • Provides market data and forecasts to 2022
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on self-administered subcutaneous drug product commercialization
  • Evaluates the impact of economic, technology, and regulatory factors

Table of Contents

Executive Summary

Subcutaneous Drug Delivery - Market Dynamics

  • Subcutaneous Delivery - Why it's Growing
    • The Evolving Drug Pipeline
    • Device and Packaging Technology Advances
    • Shifting Patient Demographics
    • Healthcare Economics
  • Demand Drivers
    • The Trend toward Self-Administration
    • Innovation in Prefilled Device Designs
    • Therapeutic Targets and Treatment
  • Competitive Landscape
  • Risk Factors

SC Delivery Device Design Factors

  • Ergonomics and Ease of Use
  • Safety Features
  • Needle Shielding
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Lyophilized Drugs/Reconstitution

Subcutaneously Delivered Drugs - Delivery Device Strategies

  • Delivering Self-Administered SC Drugs
    • Handheld Devices
      • Autoinjectors
      • Pen Injectors
      • Prefilled Syringes
      • Other Handheld Devices
    • Wearable Devices
      • Patch Pumps
      • Large Volume Wearable Devices

SC Self-Administration - Product Analysis & Forecasts by Therapeutic Sector

  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Diabetes
  • Hematopoietics
  • Hormone Replacement
  • Neurology
  • Osteoporosis
  • Reproductive Health

Market Factors

  • Regulatory Issues
  • DTC Marketing
  • Patient Education

Company Profiles

Back to Top